Mayo Clinic · 3 months ago
Research Fellow-Nephrology
Jacksonville, FL, United States
Full-time
Onsite
New Grad
$64K/yr - $75K/yrMayo Clinic is seeking a Research Fellow in Nephrology to join their innovative glomerular disease research program. This full-time, 1-year paid fellowship will provide in-depth training in clinical research, outcomes analysis, and healthcare innovation related to IgA Nephropathy and other glomerular diseases.
BiotechnologyHealth CareHospitalMedicalWellness
Responsibilities
Advance patient-centered research in IgA Nephropathy and Glomerular Disease
Master clinical research methods, grant writing, and data presentation
Implement AI tools to enhance clinical and pathological data extraction
Lead/co-author ≥2 peer-reviewed publications
Submit at least 1 national/regional abstract
Conduct ≥2 original research projects
Apply AI/NLP tools to GN data & biopsy registries
Qualification
Required
Full-time availability for a 1-year paid program
In-depth training in clinical research, outcomes analysis, and healthcare innovation related to IgA Nephropathy and other glomerular diseases
Ability to work within Mayo Clinic's Glomerular Disease Clinic Faculty
Collaboration with a multidisciplinary team of experts
Mastery of clinical research methods, grant writing, and data presentation
Lead/co-author ≥2 peer-reviewed publications
Submit at least 1 national/regional abstract
Conduct ≥2 original research projects
Apply AI/NLP tools to GN data & biopsy registries
Company
Mayo Clinic
MayoClinic is a nonprofit medical practice and medical research group focused on integrated health care, education, and research.
Founded in 1864
10001+ employees
H1B Sponsorship
Mayo Clinic has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (580)
2024 (476)
2023 (491)
2022 (509)
2021 (389)
2020 (583)
Funding
Current Stage
Late StageTotal Funding
$399.05MKey Investors
The ALS AssociationNational Institute of Neurological Disorders and StrokeAmerican Heart Association
2025-12-04Grant· $0.95M
2024-09-24Grant· $12M
2023-07-26Grant
Leadership Team
Gianrico Farrugia
President and CEO
Richard Gray
Chief Executive Officer
Recent News
Medical Xpress - latest medical and health news stories
2026-01-16
2026-01-16
BioWorld Financial Watch
2026-01-16
Company data provided by crunchbase